Raiffeisen Bank International »

Revolution Medicines shares owned by Raiffeisen Bank International

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by Raiffeisen Bank International from 13F filings

Historical chart of Raiffeisen Bank International investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by Raiffeisen Bank International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by Raiffeisen Bank International

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.9M 20k 192.62
2026-03-31 $2.4M 26k 92.71

More positions owned by Raiffeisen Bank International

Nvidia Corp Common Stock (NVDA)
Alphabet Common Stock (GOOGL)
Apple Common Stock (AAPL)
Broadcom Common Stock (AVGO)
Amazoncom Common Stock (AMZN)
Applied Materials Common Stock (AMAT)
Eli Lilly & Co Common Stock (LLY)
Lam Research Corp Common Stock (LRCX)
Advanced Micro Devices Common Stock (AMD)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Micron Technology Common Stock (MU)
Cisco Systems Common Stock (CSCO)
Jpmorgan Chase & Co Common Stock (JPM)
Abbvie Common Stock (ABBV)
Kla Corp Common Stock (KLAC)

View all positions for Raiffeisen Bank International

Top funds holding Revolution Medicines

BlackRock
Farallon Capital Management
FMR
Baker Bros. Advisors
Jupiter Topco
Darwin Global Management
Henderson Group
Vanguard Capital Management
Vanguard Portfolio Management
Nextech Invest
Paradigm Biocapital Advisors
UBS Group
State Street Corporation
Geode Capital Management
Wellington Management Company

View all funds holding Revolution Medicines